Skip to main content
. 2019 Apr 30;9:6693. doi: 10.1038/s41598-019-42328-1

Figure 4.

Figure 4

knockdown FHL2 prevents angiotensin II-induced Rac1 activation and cytoskeleton rearrangement in podocytes in vitro. Panel a: A representative western blot of FHL2, active- and total Rac1 expression after angiotensin II treatment in cultured podocytes. Panel b: Quantification of FHL2 expression (n = 3). Panel c: Quantification of active-Rac1 (n = 3). Panel d: Representative figures of podocytes lamellipodium formation and migration. Panel e: Quantification of migrated podocyte number (n = 3). Panel f: Co-immunoprecipitation (Co-IP) confirmed FHL2 and FAK has structural protein-protein interaction in podocytes. *p < 0.05, **p < 0.01 compared to control.